Sie befinden sich hier:


AOP Orphan Contact

AOP Orphan worldwide

Wilhelminenstraße 91/IIf
1160 Vienna, Austria
office(at)aoporphan.com

Vision & strategy


Success as an Orphan Disease Specialist

For many years large pharmaceutical companies paid little attention to Orphan Diseases and to the plight of those unfortunate patients afflicted by them. However, at AOP Orphan, we recognized the urgent need of these patients and saw an entrepreneurial opportunity to operate successfully in this small segment.

Our unique vision arose from our findings that patients with Rare Diseases are often ignored and that specialists in this small niche are rare and hard to find. Large pharmaceutical companies were of little help because they failed to concentrate on Rare Diseases due to the lack of financial incentives.

However our CEO Dr. Rudolf Widmann, was determined to establish a successful company specialized in Orphan Diseases in order to finally give hope to people afflicted with Rare Diseases - and he did. In 1996, Dr. Rudolf Widmann set up AOP Orphan Pharmaceuticals AG in Vienna and focused on product development and the production and distribution of licensed products. 

At first we simply focused on our home market in Austria but as we became more successful, we began to expand from Austria into Eastern Europe. Today our key markets are found in the EU, Switzerland and the Middle East and we have partners on all five continents. Nevertheless, although we have increased in size, we have never lost sight of our greatest asset - the physicians. We enjoy close ties to physicians in each of our markets, not least in Austria, enabling us to be of greater assistance to the patients.